APRIL 2019

CAVADEXTRIN® REDUCES PLAQUE WITHIN 4 WEEKS

CAVADEXTRIN® was administered to our first patient in our Melbourne clinic in April 2019 and within 4 weeks the plaque was reduced.

CAVADEXTRIN® circulates around the cardiovascular system removing built up cholesterol and plaque resulting in significant plaque reduction.

CAVADEXTRIN® is absorbed via intravenous application or as an enema only. If taken orally it is destroyed in the gut and has no effect.

12 grams of CAVADEXTRIN® was administered for 17 days over a 30 day period. STUNNING RESULTS! Lipids drop. Liver improves.

Lipids

Cholesterol from 10.6 (409) down to 5.5 (212)
Triglycerides from 20.0 (1771) down to 6.5 (575)
LDL from 3.7 (143) down to 1.8 (69)

Liver

GGT from 102 down to 78
ALT from 65 down to 48
AST from 42 down to 31